Assessment of the effectiveness of cancer therapy using PET.
Assessment of the effectiveness of cancer therapy using PET.
批准号:
06670914
负责人:
ISHIGAKI Takeo
金额:
$1.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Morphologiacal imaging strategies such as plain radiography, X-ray CT,MRI and ultrasonography have been used for the evaluation of cancer treatment. The shape and diameter of tumor are compared before and after the treatment. Occasionally, we meet the cases of residual mass without viable tumor cells after the therapy. And there are many cases of early recurrent disease even if we could not identify the residual mass just after the treatment. Morphological approach has limited ability in the assessment of cancer therapy.FDG-PET has been accepted as a useful diagnostic tool in oncology. We applied FDG-PET study to the assessment of cancer treatment and compared with the morphological methods. Three consecutive FDG-PET studies before, in the middle of and after the radiation therapy were performed in fifteen patients with non-small cell lung carcinomas. FDG accumulation to the tumors were compared in three scans of each patient. Reduction of tumor size measured by plain radiography or CT … More after the treatment was correlated to FDG accumulation in most of the patients. However, there were some patients without agreement between morphological study and FDG-PET.These results suggest that FDG-PET has different information on the number of tumor cells and metabolic activity.Cellularity of the tumor and partial volume effect were studied, as a basic study of FDG uptake to tumor. Thirty-seven patients with suspected recurrent disease of rectal cancer were studied with FDG-PET.Correlation between the size of tumors and the FDG uptake was studied. FDG accumulation was compared to cellularity observed in histopathological examinations in several subjects. Positive correlation was found between the size and the uptake. This suggests that the size of the tumor should be taken into consideration for accurate estimation of FDG uptake. There was a correlation between cellularity and FDG uptake. When FDG-PET is used for the evaluation of therapy, the accumulation of FDG is considered to be dependent on the number of residual tumor cells.FDG-PET is able to provide new information, which could not be obtained by conventional morphological diagnostic imaging technique. FDG-PET is aeffective method for the assessment of cancer therapy. Less
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ito K,Kato T,Ohta T,Tadokoro M,Yamada T,Ikeda M,Nishino M,Ishigaki T,Ito K,Gambhir S.: "Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer : relation to tumour size and cellularity." European Journal of Nuclear Medic
Ito K,Kato T,Ohta T,Tadokoro M,Yamada T,Ikeda M,Nishino M,Ishigaki T,Ito K,Gambhir S.:“氟-18氟-2-脱氧葡萄糖正电子发射断层扫描在复发性直肠癌中的应用:与复发性直肠癌的关系
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ito K,Kato T,Ohta T,Tadokoro M,Yamada T,Ikeda M,Nishino M,Ishigaki T: "Fluorine-18 fluoro-2-deoxyglucose positron emission tomogtaphy in recurrent rectal concer : relation to tumor size and cellularity." European Journal of Naclear Medicine. 23. 1372-1377
Ito K、Kato T、Ohta T、Tadokoro M、Yamada T、Ikeda M、Nishino M、Ishigaki T:“复发性直肠癌中的氟 18 氟-2-脱氧葡萄糖正电子发射断层扫描:与肿瘤大小和细胞构成的关系。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ito k, Kato T, ohta T, Todolorc H, Yorada T, Ikeda, M Nielinop, Ishigaki T: "Fluorine-18 Fluoro-2-deoxyglucose positron emisslon tonography in recurrent rectal cancer: relation to tumour size and cellutarity." European Journal of Naclear Medicine. 23. 137
Ito k、Kato T、ohta T、Todolorc H、Yorada T、Ikeda、M Nielinop、Ishigaki T:“复发性直肠癌中的氟 18 氟 2-脱氧葡萄糖正电子发射断层扫描:与肿瘤大小和细胞性的关系。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kato T: "Fluorodeoxyglucose positron emission tomography in pancreatic cancer:an unsolved problem" European Journal of Nuclear Medicine. 22. 32-39 (1995)
Kato T:“胰腺癌中的氟脱氧葡萄糖正电子发射断层扫描:一个未解决的问题”欧洲核医学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
伊藤健吾: "画像診断の親展開-MRI、PETが可能にした病態把握-悪性腫瘍" 最新医学. 49. 96-102 (1994)
Kengo Ito:“图像诊断的先进发展 - 通过 MRI 和 PET 使了解病理状况成为可能 - 恶性肿瘤” 现代医学 49. 96-102 (1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
Examination of the safety of the exclusive liquid crystal display monitor for diagnostic imaging and research on the test picture development for accuracy management.
-
批准号:15390359
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.44万
-
财政年份:2003
-
负责人:ISHIGAKI Takeo
-
依托单位:
Theoretical analysis of diagnostic process of medical image and optimization of CRT image processing
-
批准号:09307016
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$12.29万
-
财政年份:1997
-
负责人:ISHIGAKI Takeo
-
依托单位:
Generation of the workstation for image interpretation based on observer's diagnosis process
-
批准号:07557238
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$5.31万
-
财政年份:1995
-
负责人:ISHIGAKI Takeo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于薄层增强CT联合18F-FDG PET/CT评估直接手术的非小细胞肺癌患者纵隔淋巴结转移及其预后的研究
-
批准号:2026JJ82072
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨晓煌
-
依托单位:
肺腺癌糖代谢靶点TPI 1表达的机制及基于18F-FDG PET/CT影像的深度学习预测模型研究
-
批准号:JCZRLH202601650
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
雌激素受体阳性乳腺癌新辅助治疗早期应答机制与预测模型研究:基于18F-FDG/18F-FES PET/CT的代谢-受体整合分析
-
批准号:2026JJ82385
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张艳银
-
依托单位:
基于多模态18F-FDG及18F-FAPI PET/CT影像特征预测口腔鳞癌新辅助化学免疫治疗应答及构建预后预测模型
-
批准号:JCZRLH202600661
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于双时间相18F-FDG PET/CT显像多参数对胆管上皮癌亚型治疗决策的影响与分子靶点的相关性研究
-
批准号:2025JJ80709
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:毛志群
-
依托单位:
基于深度学习和同时注射18F-FDG和18F-AV45双示踪剂动态PET/MR成像在阿尔茨海默病早期诊断的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈冬河
-
依托单位:
18F-FDG PET-CT影像组学优化弥漫大B细胞淋巴瘤疗效评价和治疗指导的探索性研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:5.0万元
-
批准年份:2024
-
负责人:姜时雨
-
依托单位:
基于18F-FDG PET/CT影像利用GWAS分析预测非小细胞肺癌基因组突变的研究
-
批准号:82302249
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:万冬一
-
依托单位:
基于FDG PET双时间点扫描的简化动力学成像方法研究
-
批准号:12305379
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:吴婧
-
依托单位:
基于18F-FDG PET/CT深度学习预测肝癌免疫微环境并评估CIK细胞免疫治疗响应性
-
批准号:--
-
项目类别:--
-
资助金额:52万元
-
批准年份:2022
-
负责人:李小凤
-
依托单位: